Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0001209191-15-057197

President and CEO acquired 22,727 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Pomerantz Roger · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2015-06-26 Conversion : show line 1 in the form +22,727 22,727 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2015-06-26 Conversion : show line 2 in the form Series B Convertible Preferred Stock −22,727 22,727 0 D
Loading xslF345X03/doc4.xml…